AZATADINE MALEATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for azatadine maleate and what is the scope of patent protection?
Azatadine maleate
is the generic ingredient in two branded drugs marketed by Schering and is included in two NDAs. Additional information is available in the individual branded drug profile pages.There are two drug master file entries for azatadine maleate.
Summary for AZATADINE MALEATE
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 1 |
NDAs: | 2 |
Drug Master File Entries: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 98 |
Patent Applications: | 6,101 |
DailyMed Link: | AZATADINE MALEATE at DailyMed |
US Patents and Regulatory Information for AZATADINE MALEATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | OPTIMINE | azatadine maleate | TABLET;ORAL | 017601-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Schering | TRINALIN | azatadine maleate; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 018506-001 | Mar 23, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for AZATADINE MALEATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Schering | OPTIMINE | azatadine maleate | TABLET;ORAL | 017601-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Schering | OPTIMINE | azatadine maleate | TABLET;ORAL | 017601-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |